http://www.fpnotebook.com/
ADHD Medication
Aka: ADHD Medication, ADHD Stimulant- General
- Medication is not a cure, only control
- Medication holiday is not needed
- Medication should be taken on weekends and holidays
- Summer use of medication is optional
- Restart medication well before school
- Do not trial off medication at onset of school year
- Myths (Stimulant non-causes)
- Stimulants do not cause Sedation
- Stimulants do not cause growth delay
- Weight does however need to be watched closely
- Stimulants do not cause drug addiction
- Drug Abuse occurs six times more commonly in Attention Deficit
- Stimulants do not increase that risk (and might decrease Substance Abuse risk)
- Diversion is a higher risk
- Contraindications
- See Specific medications
- Age under 6 years old (may be used in ages 4-5 years old for severe refractory symptoms)
- If used in ages 4-5 years old, start with short-acting low dose Methylphenidate (slower metabolism in young children)
- Cardiovascular risks (relative)
- Stimulants are not associated with increased cardiovascular events
- (2012) Presc Lett 19(2): 12
- Monitor Blood Pressure and Heart Rate
- Reasons to avoid stimulants
- Uncontrolled Hypertension
- Serious arrhythmias
- Symptomatic heart disease
- Recent cardiovascular event
- Congenital heart defect (ask related PMH, Family History and screen on ADHD exam)
- Consider an EKG before prescribing
- Vetter (2008) Circulation 117(18):2407-23.
- Stimulants are not associated with increased cardiovascular events
- Management: Medication Protocol
- Start with short acting first-line stimulant (below)
- Advance dose to desired affect and per adverse affects
- Advance to combine long-acting with short-acting agents
- Consider rapid onset long-acting agents as single med
- Converting between stimulants
- Methylphenidate 1 mg is roughly equivalent to 0.5 mg Amphetamine salt, Dextroamphetamine or dexmethylphenidate
- Concerta 18 mg/day is roughly equivalent to Methylphenidate 15 mg/day
- Switching from Adderall to Dextroamphetamine or Methylphenidate
- Start with same total daily dose and titrate up for effect
- Switching from Methylphenidate to Adderall
- Start with one half of total daily dose and adjust based on effect and adverse effects
- Management: First Line Medications (Stimulants)
- Rapid Onset agents with short duration
- Rapid Onset agents with long duration
- Duration 8 hours
- Methylphenidate LA (Ritalin LA)
- Duration 10 hours
- Amphetamine-Dextroamphetamine (Adderall XR, Focalin XR)
- Duration 12 hours
- Methylphenidate (Concerta, Daytrana, Vyvanse)
- Duration 8 hours
- Agents to use if Substance Abuse is a concern (see myths above)
- Slow Onset agents with long duration (not recommended)
- Methylphenidate (Ritalin-SR or Metadate ER)
- Dextroamphetamine (Dexedrine Spansules)
- Equivalent dosages
- Methylphenidate (Ritalin) 20 mg SR
- Dextroamphetamine (Dexedrine) 10 mg spansules
- Investigational Agents (Stimulant)
- Agents avoided due to toxicity risk
- Management: Second-Line Medications
- Atomoxetine (Strattera) - Non-stimulant agent
- Management: Third Line Medications
- Newer Antidepressants
- Indications
- Comorbid Major Depression
- Hyper-focused on activity (e.g. computer games)
- Obsessive-Compulsive type unproductive behavior
- Agents
- Indications
- Tricyclic Antidepressants
- Indications
- Agents
- Imipramine (Preferred of tricyclics)
- Start 10 mg PO qhs (Up to 150 mg/day divided bid)
- Desipramine (Risk of sudden CV death)
- Start 10 mg PO qhs (Up to 150 mg/day divided bid)
- Imipramine (Preferred of tricyclics)
- Newer Antidepressants
- Management: Adjunctive medications for modulating emotions
- Indications
- Impulsivity
- Hyperactivity
- Conduct problems
- Tics (Tourette's)
- Agents
- Clonidine 0.05 mg PO qhs to 0.4 mg/day divided tid
- Guanfacine (Tenex)
- Beta Blocker
- Carbamazepine (Tegretol)
- Divalproex (Depakote)
- Other specific agents
- Risperidone (Risperdal)
- Indicated for severe Oppositional Defiant Disorder
- Wellbutrin (Bupropion)
- Indicated for aggression
- Risperidone (Risperdal)
- Indications
- References